Latest News
Vesuvius 'resilient' as revenue and earnings slip in first half
Vesuvius reported a “resilient” first half performance on Thursday, in line with the prior year, despite what it described as “challenging” steel markets outside of China and light vehicle-related markets in its foundry operations.
Brewin Dolphin total funds grow despite 'challenging' conditions
Wealth manager Brewin Dolphin saw total funds increase in the third quarter, driven by good inflows and investment performance.
Lancashire Holdings profit drops in 'more cautious' underwriting environment
First-half profit at Lancashire Holdings fell, the insurer said on Thursday, amid a "more cautious" underwriting environment.
German business confidence deteriorates in July - Ifo
German business confidence deteriorated more than expected in July, to its worst level since April 2013, according to a widely-followed survey released on Friday.
Victrex 'cautious' on automotive as Q3 revenues fall
Polymer manufacturer Victrex said third quarter revenues fell 14% as growth in its aerospace, energy and medical sectors was offset by “some deterioration” in its automotive and electronics businesses.
Countryside Properties 'encouraged' by sales rate despite dip in selling prices
UK homebuilder Countryside Properties said on Thursday that it performed in line with full-year expectations during the three months ended 30 June, with completions and average selling prices broadly flat year-on-year.
Sage sees operating profit margin at 'lower end' of guidance
Business technology provider Sage saw organic and recurring revenues increase in the first nine months of the year, putting it on track to "slightly exceed" full-year guidance but a warning that the organic operating profit margin would be "at the lower end" of guidance sent shares falling.
Capital & Counties to demerge Covent Garden as standalone REIT
Capital & Counties Properties announced its intention to launch Covent Garden as a central London-focussed real estate investment trust by way of a demerger on Thursday.
Covent Garden growth underpins first half at CapCo
Capital & Counties Properties reported continuing rental income growth in its half-year results on Thursday, while its equity attributable to owners slipped to £2. 6bn from £2. 7bn at the end of the 2018 financial year.
Morgan Advanced Materials backs annual guidance as H1 profit rises
Morgan Advanced Materials reported a rise in half-year profit and revenue on Thursday as it reaffirmed expectations for the full year.
NewRiver REIT portfolio 'resilient' amid turbulent retail environment
NewRiver REIT reported “good progress” with its strategies to deliver underlying funds from operations growth, and to re-establish its dividend cover in the first quarter.
National Express trading ahead of expectations, H1 profit jumps
National Express reported a jump in first-half profit on Thursday, with revenue growth in all of its main divisions and current trading ahead of expectations.
Howden Joinery stockpiles for no-deal Brexit as interims rise
Howden Joinery said it had stockpiled £12m in additional inventory to prepare for a no-deal Brexit as interim pre-tax profits rose 13. 5% to £68. 8m.
Relx backs full-year guidance as organic revenue growth slows
Relx reported a slowdown in interim organic revenue growth on Thursday but backed its guidance for the full year.
TBC Bank chairman and deputy step down amid money laundering allegations
TBC Bank Group announced on Thursday that its chairman and deputy chairman have decided to step down from its board, with immediate effect.
Wizz Air ups FY capacity growth rate as it swings to Q1 profit
Budget airline Wizz Air lifted its full-year capacity growth rate on Thursday as it said it swung to a profit in the first quarter.
Hikma signs exclusive agreement with Richter for cariprazine
Hikma Pharmaceuticals announced the signing of an exclusive license agreement to commercialise cariprazine - a novel antipsychotic - in certain Middle East and North Africa (MENA) markets on Thursday.
AstraZeneca lifts product sales guidance after solid first half
AstraZeneca reported first-half product sales growth of 12%, or 17% at constant exchange rates, to $11. 18bn (£8. 96bn) in its interim results on Thursday, including an acceleration in second-quarter product sales to $5. 72bn, which was ahead 14% year-on-year, or 19% at constant currency.
Europe open: Earnings blizzard boost shares; eyes on ECB
European shares opened higher on Thursday, as the market digested an avalanche of earnings reports and ahead of a European Central Bank rate decision.
Softcat sees FY operating profit ahead of prior expectations
IT infrastructure firm Softcat said on Thursday that full-year operating profit is now likely to be ahead of its prior expectations.